PCV73 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS WARFARIN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN THE JAPANESE HEALTHCARE SETTING
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.798
https://www.valueinhealthjournal.com/article/S1098-3015(19)33176-6/fulltext
Title :
PCV73 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS WARFARIN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN THE JAPANESE HEALTHCARE SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33176-6&doi=10.1016/j.jval.2019.09.798
First page :
Section Title :
Open access? :
No
Section Order :
10699